Pulse Biosciences Reports Q2 2026 Financial Results

What Happened

• On August 6, 2026, Pulse Biosciences, Inc. (PLSE) filed a Form 8‑K (Item 2.02) to announce certain financial and operational results for the fiscal quarter ended June 30, 2026. The company attached a press release dated August 6, 2026 as Exhibit 99.1 that summarizes its second quarter 2026 results.
• The 8‑K states this information is being furnished (not “filed”) under the Exchange Act and is incorporated by reference only as set forth in the filing.

Key Details

• Filing date: August 6, 2026; quarter reported: fiscal quarter ended June 30, 2026.
• Press release attached as Exhibit 99.1: “Business Updates and Second Quarter 2026 Financial Results.”
• Interactive XBRL cover page included with the filing (Inline XBRL).

Why It Matters

• This filing notifies investors that Pulse has released its quarterly results and accompanying business updates; investors should review the attached press release for concrete metrics such as revenue, net income (or loss), cash position, and any operational or guidance changes.
• The legal designation (“furnished, not filed”) means the press release is disclosed to the market but is not subject to certain liabilities that apply to filed statements, so investors should rely on the press release and any subsequent filings (e.g., 10‑Q) for complete audited disclosures.